Uncovering Candidate mRNAs, Signaling Pathways and Immune Cells in Atherosclerotic Plaque and Ischemic Stroke

References

• Ding Y, Lang Y, Zhang H. Candesartan reduces neuronal apoptosis caused by ischemic stroke via regulating the FFAR1/ITGA4 pathway. Mediators Inflamm. 2022;2022:2356507. doi:10.1155/2022/2356507
   PubMed Web of Science ®Google Scholar
• Li DH, Su YF, Sun CX, Fan HF, Gao WJ. A network pharmacology-based identification study on the mechanism of Xiao-Xu-Ming decoction for cerebral ischemic stroke. Evid Based Complement Altern Med. 2020;2020:2507074. doi:10.1155/2020/2507074
   PubMedGoogle Scholar
• Feske SK. Ischemic Stroke. Am J Med. 2021;134(12):1457–1464. doi:10.1016/j.amjmed.2021.07.027
   PubMedGoogle Scholar
• Camaré C, Pucelle M, Nègre-Salvayre A, Salvayre R. Angiogenesis in the atherosclerotic plaque. Redox Biol. 2017;12:18–34. doi:10.1016/j.redox.2017.01.007
   PubMed Web of Science ®Google Scholar
• Picano E, Paterni M. Ultrasound tissue characterization of vulnerable atherosclerotic plaque. Int J Mol Sci. 2015;16(5):10121–10133. doi:10.3390/ijms160510121
   PubMed Web of Science ®Google Scholar
• Zhou S, Liu S, Liu X, Zhuang W. Bioinformatics gene analysis of potential biomarkers and therapeutic targets for unstable atherosclerotic plaque-related stroke. J Mol Neurosci. 2021;71(5):1031–1045. doi:10.1007/s12031-020-01725-2
   PubMed Web of Science ®Google Scholar
• Gupta A, Baradaran H, Al-Dasuqi K, et al. Gadolinium enhancement in intracranial atherosclerotic plaque and ischemic stroke: a systematic review and meta-analysis. J Am Heart Assoc. 2016;5(8). doi:10.1161/JAHA.116.003816
   Web of Science ®Google Scholar
• Clough E, Barrett T. The gene expression omnibus database. Methods Mol Biol. 2016;1418:93–110.
   PubMedGoogle Scholar
• Šimundić AM. Measures of diagnostic accuracy: basic definitions. Ejifcc. 2009;19(4):203–211.
   PubMedGoogle Scholar
• Charoentong P, Finotello F, Angelova M, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248–262. doi:10.1016/j.celrep.2016.12.019
   PubMed Web of Science ®Google Scholar
• Barroso I. ADCY3, neuronal primary cilia and obesity. Nat Genet. 2018;50(2):166–167. doi:10.1038/s41588-018-0043-x
   PubMed Web of Science ®Google Scholar
• Zou J, Wu K, Lin C, Jie ZG. LINC00319 acts as a microRNA-335-5p sponge to accelerate tumor growth and metastasis in gastric cancer by upregulating ADCY3. Am J Physiol Gastrointest Liver Physiol. 2020;318(1):G10–g22. doi:10.1152/ajpgi.00405.2018
   PubMed Web of Science ®Google Scholar
• Liu Y, Huan W, Wu J, Zou S, Qu L. IGFBP6 is downregulated in unstable carotid atherosclerotic plaques according to an integrated bioinformatics analysis and experimental verification. J Atheroscler Thromb. 2020;27(10):1068–1085. doi:10.5551/jat.52993
   PubMed Web of Science ®Google Scholar
• Hou Y, Hou L, Liang Y, et al. The p53-inducible CLDN7 regulates colorectal tumorigenesis and has prognostic significance. Neoplasia. 2020;22(11):590–603. doi:10.1016/j.neo.2020.09.001
   PubMed Web of Science ®Google Scholar
• Wu Z, Shi J, Song Y, et al. Claudin-7 (CLDN7) is overexpressed in gastric cancer and promotes gastric cancer cell proliferation, invasion and maintains mesenchymal state. Neoplasma. 2018;65(3):349–359. doi:10.4149/neo_2018_170320N200
   PubMed Web of Science ®Google Scholar
• Zoladek J, Legros V, Jeannin P, et al. Zika virus requires the expression of claudin-7 for optimal replication in human endothelial cells. Front Microbiol. 2021;12:746589. doi:10.3389/fmicb.2021.746589
   PubMed Web of Science ®Google Scholar
• Park JH, Hale TK, Smith RJ, Yang T. PPM1B depletion induces premature senescence in human IMR-90 fibroblasts. Mech Ageing Dev. 2014;138:45–52. doi:10.1016/j.mad.2014.03.003
   PubMed Web of Science ®Google Scholar
• Wei J, Liang BS. PPM1B and P-IKKβ expression levels correlated inversely with rat gastrocnemius atrophy after denervation. Braz J Med Biol Res. 2012;45(8):711–715. doi:10.1590/S0100-879X2012007500080
   PubMed Web of Science ®Google Scholar
• Weinstock NI, Sadler L. The RRAS2 pathogenic variant p.Q72L produces severe Noonan syndrome with hydrocephalus: a case report. Am J Med Genet A. 2022;188(1):364–368. doi:10.1002/ajmg.a.62523
   PubMed Web of Science ®Google Scholar
• Janapati S, Wurtzel J, Dangelmaier C, et al. TC21/RRas2 regulates glycoprotein VI-FcRγ-mediated platelet activation and thrombus stability. J Thromb Haemost. 2018;16:1632–1645. doi:10.1111/jth.14197
   Web of Science ®Google Scholar
• Gutierrez-Erlandsson S, Herrero-Vidal P, Fernandez-Alfara M, et al. R-RAS2 overexpression in tumors of the human central nervous system. Mol Cancer. 2013;12(1):127. doi:10.1186/1476-4598-12-127
   PubMedGoogle Scholar
• Romagnani S. Th1/Th2 cells. Inflamm Bowel Dis. 1999;5(4):285–294. doi:10.1097/00054725-199911000-00009
   PubMed Web of Science ®Google Scholar
• Vogelgesang A, May VE, Grunwald U, et al. Functional status of peripheral blood T-cells in ischemic stroke patients. PLoS One. 2010;5(1):e8718. doi:10.1371/journal.pone.0008718
   PubMed Web of Science ®Google Scholar
• Prass K, Meisel C, Höflich C, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med. 2003;198(5):725–736. doi:10.1084/jem.20021098
   PubMed Web of Science ®Google Scholar
• Liu R, Song P, Gu X, et al. Comprehensive landscape of immune infiltration and aberrant pathway activation in ischemic stroke. Front Immunol. 2021;12:766724. doi:10.3389/fimmu.2021.766724
   PubMed Web of Science ®Google Scholar
• Depuydt MAC, Schaftenaar FH, Prange KHM, et al. Single-cell T cell receptor sequencing of paired human atherosclerotic plaques and blood reveals autoimmune-like features of expanded effector T cells. Nat Cardiovasc Res. 2023;2(2):112–125. doi:10.1038/s44161-022-00208-4
   PubMedGoogle Scholar
• Wang Z, Zhang X, Lu S, et al. Pairing of single-cell RNA analysis and T cell antigen receptor profiling indicates breakdown of T cell tolerance checkpoints in atherosclerosis. Nat Cardiovasc Res. 2023;2(3):290–306. doi:10.1038/s44161-023-00218-w
   PubMedGoogle Scholar
• Li L, Lou W, Li H, Zhu Y, Huang X. Upregulated C-C Motif chemokine ligand 2 promotes ischemic stroke via chemokine signaling pathway. Ann Vasc Surg. 2020;68:476–486. doi:10.1016/j.avsg.2020.04.047
   PubMed Web of Science ®Google Scholar
• Bäck M, Weber C, Lutgens E. Regulation of atherosclerotic plaque inflammation. J Intern Med. 2015;278(5):462–482. doi:10.1111/joim.12367
   PubMed Web of Science ®Google Scholar
• Hansson GK, Robertson AK, Söderberg-Nauclér C. Inflammation and atherosclerosis. Annu Rev Pathol. 2006;1:297–329. doi:10.1146/annurev.pathol.1.110304.100100
   PubMed Web of Science ®Google Scholar
• Guo F, Xu D, Lin Y, et al. Chemokine CCL2 contributes to BBB disruption via the p38 MAPK signaling pathway following acute intracerebral hemorrhage. FASEB J. 2020;34(1):1872–1884. doi:10.1096/fj.201902203RR
   PubMed Web of Science ®Google Scholar
• Xiang Y, Zhang Y, Xia Y, Zhao H, Liu A, Chen Y. LncRNA MEG3 targeting miR-424-5p via MAPK signaling pathway mediates neuronal apoptosis in ischemic stroke. Aging. 2020;12(4):3156–3174. doi:10.18632/aging.102790
   PubMedGoogle Scholar
• Tian R, Wu B, Fu C, Guo K. miR-137 prevents inflammatory response, oxidative stress, neuronal injury and cognitive impairment via blockade of Src-mediated MAPK signaling pathway in ischemic stroke. Aging. 2020;12(11):10873–10895. doi:10.18632/aging.103301
   PubMedGoogle Scholar
• Fang S, Sun S, Cai H, et al. IRGM/Irgm1 facilitates macrophage apoptosis through ROS generation and MAPK signal transduction: irgm1(±) mice display increases atherosclerotic plaque stability. Theranostics. 2021;11(19):9358–9375. doi:10.7150/thno.62797
   PubMed Web of Science ®Google Scholar
• Gao X, Zhang X, Cui L, et al. Ginsenoside Rb1 promotes motor functional recovery and axonal regeneration in post-stroke mice through cAMP/PKA/CREB signaling pathway. Brain Res Bull. 2020;154:51–60. doi:10.1016/j.brainresbull.2019.10.006
   PubMed Web of Science ®Google Scholar
• Xin M, Feng J, Hao Y, et al. Cyclic adenosine monophosphate in acute ischemic stroke: some to update, more to explore. J Neurol Sci. 2020;413:116775. doi:10.1016/j.jns.2020.116775
   PubMed Web of Science ®Google Scholar
• Fantidis P. The role of intracellular 3’5’-cyclic adenosine monophosphate (cAMP) in atherosclerosis. Curr Vasc Pharmacol. 2010;8(4):464–472. doi:10.2174/157016110791330843
   PubMed Web of Science ®Google Scholar
• Zhou Y, Cao ZQ, Wang HY, et al. The anti-inflammatory effects of Morin hydrate in atherosclerosis is associated with autophagy induction through cAMP signaling. Mol Nutr Food Res. 2017;61(9):1600966. doi:10.1002/mnfr.201600966
   Web of Science ®Google Scholar
• Chen JS, Wang HK, Hsu CY, et al. HDAC1 deregulation promotes neuronal loss and deficit of motor function in stroke pathogenesis. Sci Rep. 2021;11(1):16354. doi:10.1038/s41598-021-95837-3
   PubMed Web of Science ®Google Scholar
• Chen JS, Wang HK. Restoration of HDAC1 enzymatic activity after stroke protects neurons from ischemia/reperfusion damage and attenuates behavioral deficits in rats. Int J Mol Sci. 2021;22(19):1.
   Web of Science ®Google Scholar
• Liu H, Wang H, Ma J, Qiao Z, Zhang L, Ge G. MicroRNA-146a-3p/HDAC1/KLF5/IKBα signal axis modulates plaque formation of atherosclerosis mice. Life Sci. 2021;284:119615. doi:10.1016/j.lfs.2021.119615
   PubMed Web of Science ®Google Scholar
• Su Z, Lu H, Jiang H, et al. IFN-γ-producing Th17 cells bias by HMGB1-T-bet/RUNX3 axis might contribute to progression of coronary artery atherosclerosis. Atherosclerosis. 2015;243(2):421–428. doi:10.1016/j.atherosclerosis.2015.09.037
   PubMed Web of Science ®Google Scholar
• Liu Q, Jin WN, Liu Y, et al. Brain ischemia suppresses immunity in the periphery and brain via different neurogenic innervations. Immunity. 2017;46(3):474–487. doi:10.1016/j.immuni.2017.02.015
   PubMed Web of Science ®Google Scholar
• Mens MMJ, Heshmatollah A, Fani L, Ikram MA, Ikram MK, Ghanbari M. Circulatory MicroRNAs as potential biomarkers for stroke risk: the Rotterdam study. Stroke. 2021;52(3):945–953. doi:10.1161/STROKEAHA.120.031543
   PubMed Web of Science ®Google Scholar
• Pan Y, Jiao Q, Wei W, Zheng T, Yang X, Xin W. Emerging role of LncRNAs in ischemic stroke-novel insights into the regulation of inflammation. J Inflamm Res. 2021;14:4467–4483. doi:10.2147/JIR.S327291
   PubMed Web of Science ®Google Scholar
• Cipollone F, Felicioni L, Sarzani R, et al. A unique microRNA signature associated with plaque instability in humans. Stroke. 2011;42(9):2556–2563. doi:10.1161/STROKEAHA.110.597575
   PubMed Web of Science ®Google Scholar
• Maitrias P, Metzinger-Le Meuth V, Massy ZA, et al. MicroRNA deregulation in symptomatic carotid plaque. J Vasc Surg. 2015;62(5):1245–50.e1. doi:10.1016/j.jvs.2015.06.136
   PubMed Web of Science ®Google Scholar
• Eken SM, Jin H, Chernogubova E, et al. MicroRNA-210 enhances fibrous cap stability in advanced atherosclerotic lesions. Circ Res. 2017;120(4):633–644. doi:10.1161/CIRCRESAHA.116.309318
   PubMed Web of Science ®Google Scholar
• Fasolo F, Jin H, Winski G. Long noncoding RNA MIAT controls advanced atherosclerotic lesion formation and plaque destabilization. Circulation. 2021;144(19):1567–1583. doi:10.1161/CIRCULATIONAHA.120.052023
   PubMed Web of Science ®Google Scholar
• Pan J, Qu M, Li Y, et al. MicroRNA-126-3p/-5p overexpression attenuates blood-brain barrier disruption in a mouse model of middle cerebral artery occlusion. Stroke. 2020;51(2):619–627. doi:10.1161/STROKEAHA.119.027531
   PubMed Web of Science ®Google Scholar
• Santovito D, Egea V, Bidzhekov K. Noncanonical inhibition of caspase-3 by a nuclear microRNA confers endothelial protection by autophagy in atherosclerosis. Sci Transl Med. 2020;12(546). doi:10.1126/scitranslmed.aaz2294
   PubMed Web of Science ®Google Scholar
• Santovito D, Weber C. Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease. Nat Rev Cardiol. 2022;19(9):620–638. doi:10.1038/s41569-022-00680-2
   PubMed Web of Science ®Google Scholar
• Zhang W, Chen X, Jia J. MiR-3150b-3p inhibits the progression of colorectal cancer cells via targeting GOLPH3. J Investig Med. 2020;68(2):425–429. doi:10.1136/jim-2019-001124
   PubMed Web of Science ®Google Scholar
• Yu Z, Wang L, Li X. MiR-3150b-3p inhibits the proliferation and invasion of cervical cancer cells by targeting TNFRSF11a. J Investig Med. 2020;68(6):1166–1170. doi:10.1136/jim-2020-001284
   PubMed Web of Science ®Google Scholar
• Tang J, Wang R, Tang R, Gu P, Han J, Huang W. CircRTN4IP1 regulates the malignant progression of intrahepatic cholangiocarcinoma by sponging miR-541-5p to induce HIF1A production. Pathol Res Pract. 2022;230:153732. doi:10.1016/j.prp.2021.153732
   PubMed Web of Science ®Google Scholar
• Li D, Zhang J, Yang J, Wang J, Zhang R, Li J. CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition. Cell Death Dis. 2021;13(1):12. doi:10.1038/s41419-021-04464-3
   PubMed Web of Science ®Google Scholar
• Yang H, Zhang Y, Chen H, et al. Mir-184 contributes to brain injury through targeting PPAP2B following ischemic stroke in male rats. Front Mol Neurosci. 2021;14:613887. doi:10.3389/fnmol.2021.613887
   PubMed Web of Science ®Google Scholar
• Zhou L, Yang W, Yao E, et al. MicroRNA-488-3p regulates neuronal cell death in cerebral ischemic stroke through Vacuolar Protein Sorting 4B (VPS4B). Neuropsychiatr Dis Treat. 2021;17:41–55. doi:10.2147/NDT.S255666
   PubMed Web of Science ®Google Scholar
• Zheng H, Zhang G, Liu G, Wang L. Up-regulation of lncRNA NEAT1 in cerebral ischemic stroke promotes activation of astrocytes by modulation of miR-488-3p/RAC1. Exp Brain Res. 2023;241(2):395–406. doi:10.1007/s00221-022-06519-z
   PubMed Web of Science ®Google Scholar